Merck Makes Big Bet On Flu Protection With Cidara Buyout

benzinga.com/m-a/25/11/48864119/merck-makes-big-bet-on-flu-protection-with-cidara-buyout

Merck & Co. Inc. (NYSE:MRK) on Friday agreed to acquire Cidara Therapeutics, Inc. (NASDAQ:CDTX) for $221.50 per share in cash, for a total transaction value of approximately $9.2 billion.
“We continue to execute our science-led business development strategy, augmenting our pipeline with…

This story appeared on benzinga.com, 2025-11-14 14:32:24.
The Entire Business World on a Single Page. Free to Use →